1.Kool, JL. Risk of person-to-person transmission of pneumonic plague. Clinical Infectious Diseases 2005; 40: 1166–1172.
2.Khan, AS, Morse, S, Lillibridge, S. Public-health preparedness for biological terrorism in the USA. Lancet 2000; 356: 1179–1182.
3.Rotz, LD, et al. Public health assessment of potential biological terrorism agents. Emerging Infectious Diseases 2002; 8: 225–230.
4.World Health Organization. Health aspects of chemical and biological weapons 1970. 98–109.
5.107th Congress of the United States. Public Health Security and Bioterrorism Preparedness and Response Act of 2002. Public Law 107–188.
6.Inglesby, TV, Grossman, R, O'Toole, T. A plague on your city: observations from TOPOFF. Clinical Infectious Diseases 2001; 32: 436–445.
7.Anderson, RM, May, RM. Infectious Diseases of Humans: Dynamics and Control. London: Oxford University Press, 1991.
8.Rothman, KJ, Greenland, S. Modern Epidemiology, 2nd edn. Philadelphia: Lippincott, Williams & Wilkins, 1998.
9.Bauch, CT, et al. Dynamically modeling SARS and other newly emerging respiratory illnesses: past, present, and future. Epidemiology 2005; 16: 791–801.
10.Lipsitch, M, et al. Transmission dynamics and control of severe acute respiratory syndrome. Science 2003; 300: 1966–1970.
11.Lloyd-Smith, JO, et al. Superspreading and the effect of individual variation on disease emergence. Nature 2005; 438: 355–359.
12.Riley, S, et al. Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions. Science 2003; 300: 1961–1966.
13.Centers for Disease Control and Prevention.Severe acute respiratory syndrome – Singapore, 2003. Morbidity and Mortality Weekly Report 2003; 52: 405–411.
14.Shen, Z, et al. Superspreading SARS events, Beijing, 2003. Emerging Infectious Diseases 2004; 10: 256–260.
15.Gani, R, Leach, S. Epidemiologic determinants for modeling pneumonic plague outbreaks. Emerging Infectious Diseases 2004; 10: 608–614.
16.Nishiura, H, et al. Transmission potential of primary pneumonic plague: time inhomogeneous evaluation based on historical documents of the transmission network. Journal of Epidemiology and Community Health 2006; 60: 640–645.
17.Potthoff, RF, Whittinghill, M. Testing for homogeneity. II. The Poisson distribution. Biometrika 1966; 53: 183–190.
18.Wong, D, et al. Primary pneumonic plague contracted from a mountain lion carcass. Clinical Infectious Diseases 2009; 49: e33–38.
19.Blue, R. History of Plague cases 116 and 117. Public Health Reports 1904; 19: 359–360.
20.Kellogg, WH. An epidemic of pneumonic plague. American Journal of Public Health (New York, NY) 1920; 10: 599–605.
21.Dickie, WM. Plague in California 1900–1925. Proceedings of the Conference of State Provincial Health Authors of North America 1926, pp. 30–78.
22.Link, VB. A history of plague in United States of America. Public Health Monograph 1955; 26: 1–120.
23.Viseltear, AJ. The pneumonic plague epidemic of 1924 in Los Angeles. Yale Journal of Biology and Medicine 1974; 47: 40–54.
24.Dye, C, Gay, N. Epidemiology. Modeling the SARS epidemic. Science 2003; 300: 1884–1885.
25.Meyer, KF. Pneumonic plague. Bacteriological Reviews 1961; 25: 249–261.
26.Davis, S, et al. The abundance threshold for plague as a critical percolation phenomenon. Nature 2008; 454: 634–637.
27.Inglesby, TV, et al. Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. Journal of the American Medical Association 2000; 283: 2281–2290.
28.Morelli, G, et al. Yersinia pestis genome sequencing identifies patterns of global phylogenetic diversity. Nature Genetics 2010 42: 1140–1143.
29.World Health Organization.Plague Manual – Epidemiology, Distribution, Surveillance and Control, 1999, vol. 74, pp. 447.